Assessment of the Functional Outcome and Quality of Life in Sarcoma Patients
QOLSarcoma
1 other identifier
interventional
60
1 country
1
Brief Summary
Primary bone and soft tissue sarcomas are an exceptionally rare form of cancer, collectively accounting for only 1% of all malignancies diagnosed. Sarcomas often occur in the patients' extremities and treatment typically involves limb salvage surgery with bone and/or muscle resection. These surgeries often leave the patients with disfigurements, psychological trauma, and functional disabilities. Perhaps, the most difficult and life-altering decision that patients (and their parents) with primary bone sarcomas about the knee joint have to make, involves choosing the type of surgical procedure that will provide them with the outcome that meets their functional as well as aesthetic expectations. In literature, the quality of life for patients with osteosarcoma around the knee joint after three different surgical procedures, that is, amputation, endoprosthetic reconstruction and rotationplasty was evaluated. There was found that patients treated with rotationplasty showed significantly higher functional scores compared to the two other groups of patients. Also, researchers investigated the long-term quality of life after bone sarcoma surgery around the knee joint and found that, despite the functional disability, survivors were busy with work, study, relationships, and sometimes they have founded a family. Most published reports in the literature on assessment of gait in the lower-extremity sarcoma survivors were focused on bone sarcoma patients after wide resection and endoprosthetic reconstruction. To the knowledge of the investigator, there has been no published studies on gait analysis after resection of soft tissue sarcomas (STS) of the lower extremity. The rare and heterogeneous aspects of STS and the paucity of knowledge of movement strategies in these patients hinder the development of effective rehabilitation protocols for recovering movement after resection of STS in the lower limb.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 9, 2021
CompletedFirst Posted
Study publicly available on registry
September 21, 2021
CompletedStudy Start
First participant enrolled
October 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
March 16, 2026
March 1, 2026
5.2 years
September 9, 2021
March 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Musculoskeletal Tumor Society Score (MSTS)
To determine the physical and mental health for patients with extremity sarcoma
Within a period of 1 year
Quality of Life Questionnaire C-30 (QLQ-C30)
To measure cancer patients' physical, psychological and social functions
Within a period of 1 year
Participation and Autonomy Questionnaire Questionnaire (IPAQ)
To measure health-related physical activity
Within a period of 1 year
Study Arms (3)
Soft tissue sarcoma of the thigh
OTHERPatients who underwent surgical resection of a deep intramuscular soft tissue sarcoma of the thigh
Control group
NO INTERVENTIONA group of healthy age-matched individuals will be identified out of an available gait lab database to compare the gait pattern with tha of the patient group
Bone or soft tissue sarcoma of the lower extremity
OTHERPatients who underwent surgical resection of a bone or soft tissue sarcoma of the lower extremity
Interventions
Quality of Life Questionnaire C-30 (QLQ-C30), Impact on Participation and Autonomy Questionnaire (IPAQ) and Musculoskeletal Tumor Society Score (MSTS)
Eligibility Criteria
You may qualify if:
- Patients who underwent limb salvage surgery for bone or soft tissue sarcoma of the lower extremity at UZ Leuven
- to 95 years old
- Patients should be at least one year post surgery
- Informed consent has obtained
You may not qualify if:
- Patients who received major prior surgery of the lower limbs or with any pathology, injury or disorder known to affect the locomotor system
- Skeletally immature individuals
- No informed consent has obtained
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UZ Leuven
Leuven, Vlaams-Brabant, 3000, Belgium
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hazem Wafa
Universitaire Ziekenhuizen KU Leuven
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 9, 2021
First Posted
September 21, 2021
Study Start
October 1, 2021
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
March 16, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share